Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
Abstract The International Atomic Energy Agency (IAEA) held the 3rd International Symposium on Trends in Radiopharmaceuticals, (ISTR-2023) at IAEA Headquarters in Vienna, Austria, during the week of 16–21 April 2023. This procedural paper summarizes highlights from symposium presentations, posters,...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-11-01
|
Series: | EJNMMI Radiopharmacy and Chemistry |
Online Access: | https://doi.org/10.1186/s41181-023-00224-0 |
_version_ | 1797629885586341888 |
---|---|
author | Amirreza Jalilian Clemens Decristoforo Melissa Denecke Philip H. Elsinga Cornelia Hoehr Aruna Korde Suzanne E. Lapi Peter J. H. Scott |
author_facet | Amirreza Jalilian Clemens Decristoforo Melissa Denecke Philip H. Elsinga Cornelia Hoehr Aruna Korde Suzanne E. Lapi Peter J. H. Scott |
author_sort | Amirreza Jalilian |
collection | DOAJ |
description | Abstract The International Atomic Energy Agency (IAEA) held the 3rd International Symposium on Trends in Radiopharmaceuticals, (ISTR-2023) at IAEA Headquarters in Vienna, Austria, during the week of 16–21 April 2023. This procedural paper summarizes highlights from symposium presentations, posters, panel discussions and satellite meetings, and provides additional resources that may be useful to researchers working with diagnostic and therapeutic radiopharmaceuticals in the academic, government and industry setting amongst IAEA Member States and beyond. More than 550 participants in person from 88 Member States attended the ISTR-2023. Over 360 abstracts were presented from all over the world by a diverse group of global scientists working with radiopharmaceuticals. Given this group of international radiochemists is unique to ISTR (IAEA funding enabled many to attend), there was an invaluable wealth of knowledge on the global state of the radiopharmaceutical sciences present at the meeting. The intent of this Proceedings paper is to share this snapshot from our international colleagues with the broader radiopharmaceutical sciences community by highlighting presentations from the conference on the following topics: Isotope Production and Radiochemistry, Industrial Insights, Regional Trends, Training and Education, Women in the Radiopharmaceutical Sciences, and Future Perspectives and New Initiatives. The authors of this paper are employees of IAEA, members of the ISTR-2023 Organizing Committee and/or members of the EJNMMI Radiopharmacy and Chemistry Editorial Board who attended ISTR-2023. Overall, ISTR-2023 fostered the successful exchange of scientific ideas around every aspect of the radiopharmaceutical sciences. It was well attended by a diverse mix of radiopharmaceutical scientists from all over the world, and the oral and poster presentations provided a valuable update on the current state-of-the-art of the field amongst IAEA Member States. Presentations as well as networking amongst the attendees resulted in extensive knowledge transfer amongst the various stakeholders representing 88 IAEA Member States. This was considered particularly valuable for attendees from Member States where nuclear medicine and the radiopharmaceutical sciences are still relatively new. Since the goal is for the symposium series to be held every four years; the next one is anticipated to take place in 2027. |
first_indexed | 2024-03-11T11:00:04Z |
format | Article |
id | doaj.art-4e9dd0a4d0ae4b039a0f8acaf1807559 |
institution | Directory Open Access Journal |
issn | 2365-421X |
language | English |
last_indexed | 2024-03-11T11:00:04Z |
publishDate | 2023-11-01 |
publisher | SpringerOpen |
record_format | Article |
series | EJNMMI Radiopharmacy and Chemistry |
spelling | doaj.art-4e9dd0a4d0ae4b039a0f8acaf18075592023-11-12T12:33:58ZengSpringerOpenEJNMMI Radiopharmacy and Chemistry2365-421X2023-11-018112310.1186/s41181-023-00224-0Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)Amirreza Jalilian0Clemens Decristoforo1Melissa Denecke2Philip H. Elsinga3Cornelia Hoehr4Aruna Korde5Suzanne E. Lapi6Peter J. H. Scott7Division of Physical and Chemical Sciences, International Atomic Energy AgencyDepartment of Nuclear Medicine, Medical University InnsbruckDivision of Physical and Chemical Sciences, International Atomic Energy AgencyDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center GroningenLife Sciences Division, TRIUMFDivision of Physical and Chemical Sciences, International Atomic Energy AgencyDepartments of Radiology and Chemistry, O’Neal Comprehensive Cancer Center at UAB, University of Alabama at BirminghamDepartment of Radiology, University of MichiganAbstract The International Atomic Energy Agency (IAEA) held the 3rd International Symposium on Trends in Radiopharmaceuticals, (ISTR-2023) at IAEA Headquarters in Vienna, Austria, during the week of 16–21 April 2023. This procedural paper summarizes highlights from symposium presentations, posters, panel discussions and satellite meetings, and provides additional resources that may be useful to researchers working with diagnostic and therapeutic radiopharmaceuticals in the academic, government and industry setting amongst IAEA Member States and beyond. More than 550 participants in person from 88 Member States attended the ISTR-2023. Over 360 abstracts were presented from all over the world by a diverse group of global scientists working with radiopharmaceuticals. Given this group of international radiochemists is unique to ISTR (IAEA funding enabled many to attend), there was an invaluable wealth of knowledge on the global state of the radiopharmaceutical sciences present at the meeting. The intent of this Proceedings paper is to share this snapshot from our international colleagues with the broader radiopharmaceutical sciences community by highlighting presentations from the conference on the following topics: Isotope Production and Radiochemistry, Industrial Insights, Regional Trends, Training and Education, Women in the Radiopharmaceutical Sciences, and Future Perspectives and New Initiatives. The authors of this paper are employees of IAEA, members of the ISTR-2023 Organizing Committee and/or members of the EJNMMI Radiopharmacy and Chemistry Editorial Board who attended ISTR-2023. Overall, ISTR-2023 fostered the successful exchange of scientific ideas around every aspect of the radiopharmaceutical sciences. It was well attended by a diverse mix of radiopharmaceutical scientists from all over the world, and the oral and poster presentations provided a valuable update on the current state-of-the-art of the field amongst IAEA Member States. Presentations as well as networking amongst the attendees resulted in extensive knowledge transfer amongst the various stakeholders representing 88 IAEA Member States. This was considered particularly valuable for attendees from Member States where nuclear medicine and the radiopharmaceutical sciences are still relatively new. Since the goal is for the symposium series to be held every four years; the next one is anticipated to take place in 2027.https://doi.org/10.1186/s41181-023-00224-0 |
spellingShingle | Amirreza Jalilian Clemens Decristoforo Melissa Denecke Philip H. Elsinga Cornelia Hoehr Aruna Korde Suzanne E. Lapi Peter J. H. Scott Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) EJNMMI Radiopharmacy and Chemistry |
title | Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) |
title_full | Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) |
title_fullStr | Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) |
title_full_unstemmed | Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) |
title_short | Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) |
title_sort | proceedings of international symposium of trends in radiopharmaceuticals 2023 istr 2023 |
url | https://doi.org/10.1186/s41181-023-00224-0 |
work_keys_str_mv | AT amirrezajalilian proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT clemensdecristoforo proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT melissadenecke proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT philiphelsinga proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT corneliahoehr proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT arunakorde proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT suzanneelapi proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 AT peterjhscott proceedingsofinternationalsymposiumoftrendsinradiopharmaceuticals2023istr2023 |